CANDESARTAN EG LABO 32 mg, scored tablet 30 tablets
Active ingredients: Candesartan cilexetil
Commercialized according to BDPMDispensing in France: Prescription only
Scored tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CANDESARTAN EG LABO 32 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC aluminium de 30 comprimé(s)
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 13 Nov 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60506970CIP73030804CIP133400930308042Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CANDÉSARTAN CILEXÉTILcomprimé | 32 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.